Correlation Engine 2.0
Clear Search sequence regions


  • astrocytoma (3)
  • calcium (4)
  • Drp 1 (1)
  • flow (1)
  • glioma (7)
  • HIF 1 (2)
  • human (2)
  • MAPK (4)
  • mice (1)
  • neocortex (1)
  • neurons (2)
  • nude mice (2)
  • oligodendroglioma (3)
  • patients (2)
  • plasma membranes (1)
  • prognosis (1)
  • Rho GTPase (1)
  • RICH2 (13)
  • rt- pcr (1)
  • western blot (1)
  • Sizes of these terms reflect their relevance to your search.

    Epilepsy, a common complication of diffuse low-grade gliomas (DLGGs; diffuse oligodendroglioma and astrocytoma collectively), severely compromises the quality of life of patients. DLGG epileptogenicity may primarily be generated by interactions between the tumor and the neocortex. Neuronal uptake of dysfunctional mitochondria from the extracellular environment can lead to abnormal neuronal discharge. Mitochondrial dysfunction is frequently observed in gliomas that can transmigrate across the plasma membranes. Here, we examined the role of the Rho GTPase-activating protein 44 (RICH2) in mitochondrial dynamics and DLGG-related epilepsy. We investigated the association between mitochondrial and RICH2 expression in human DLGG tissues using immunohistochemistry. We examined the association between RICH2 and epilepsy in nude mouse glioma models by electrophysiology. The effect of RICH2 on mitochondrial morphology and calcium motility were assessed by single cell fluorescence microscopy. Quantitative RT-PCR (qRT-PCR) and Western blot analysis were performed to characterize RICH2 induced expression changes in the genes related to mitochondrial dynamics, mitogenesis and mitochondrial function. We found that RICH2 expression was higher in oligodendroglioma than in astrocytoma and was correlated with better prognosis and higher epilepsy rate in patients. The expression of mitochondria may be associated with clinical DLGG-related epilepsy and reduced by RICH2 overexpression. And RICH2 could promote DLGG-related epilepsy in tumorigenic nude mice. RICH2 overexpression decreased calcium flow and the mitochondria released from glioma cells (SW1088 and U251) into the extracellular environment, potentially via downregulation of MFN-1/MFN-2 levels which suggests reduced mitochondrial fusion. In addition, we observed decreased mitochondrial trafficking into neurons (released from glioma cells and trafficked into neurons), which could explain the higher incidence of DLGG-related epilepsy due to reduced neuroprotection. Furthermore, RICH2 downregulated MAPK/ERK/HIF-1 pathway. In conclusion, these results suggest that RICH2 could promote epilepsy by (i) inhibiting mitochondrial fusion via MFN downregulation and Drp-1 upregulation; (ii) altering the MAPK/ERK/Hif-1 signaling axis. RICH2 may be a potential target in the treatment of DLGG-related epilepsy. Copyright © 2023. Published by Elsevier Inc.

    Citation

    Jiarui Zhang, Li Gong, Huayu Zhu, Wei Sun, Jing Tian, Yan Zhang, Qiao Liu, Xiaolan Li, Fuqin Zhang, Shumei Wang, Shaojun Zhu, Dongjing Ding, Wei Zhang, Chen Yang. RICH2 decreases the mitochondrial number and affects mitochondrial localization in diffuse low-grade glioma-related epilepsy. Neurobiology of disease. 2023 Nov;188:106344

    Expand section icon Mesh Tags

    Expand section icon Substances


    PMID: 37926169

    View Full Text